|
π¦
|
The Downregulation of microRNA let-7a Contributes to the Excessive Expression of Type I Collagen in Systemic and Localized Scleroderma
13 auth.
K. Makino,
M. Jinnin,
A. Hirano,
Keitaro Yamane,
M. Eto,
Takamitsu Kusano,
N. Honda,
I. Kajihara,
T. Makino,
K. Sakai,
...
S. Masuguchi,
S. Fukushima,
H. Ihn
|
7 |
2013 |
7
π¦
|
|
π
|
TGF-Ξ²βMediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts
11 auth.
N. Honda,
M. Jinnin,
I. Kajihara,
T. Makino,
K. Makino,
S. Masuguchi,
...
S. Fukushima,
Yoshinobu Okamoto,
M. Hasegawa,
M. Fujimoto,
H. Ihn
|
7 |
2012 |
7
π
|
|
π
|
miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin Ξ²3.
12 auth.
N. Honda,
M. Jinnin,
Tomomi Kira-Etoh,
K. Makino,
I. Kajihara,
T. Makino,
...
S. Fukushima,
Y. Inoue,
Yoshinobu Okamoto,
M. Hasegawa,
M. Fujimoto,
H. Ihn
|
6 |
2013 |
6
π
|
|
π¦
|
Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis
K. Makino,
T. Makino,
L. Stawski,
K. Lipson,
A. Leask,
M. Trojanowska
|
6 |
2017 |
6
π¦
|
|
π
|
Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways
9 auth.
Agnieszka P. Grzegorzewska,
F. Seta,
Rong Han,
Caitlin A. Czajka,
K. Makino,
L. Stawski,
...
J. Isenberg,
J. Browning,
M. Trojanowska
|
5 |
2017 |
5
π
|
|
π
|
microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma
11 auth.
M. Etoh,
M. Jinnin,
K. Makino,
Keitaro Yamane,
Wakana Nakayama,
J. Aoi,
...
N. Honda,
I. Kajihara,
T. Makino,
S. Fukushima,
H. Ihn
|
5 |
2012 |
5
π
|
|
π
|
Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients
10 auth.
Hiroki Arakawa,
M. Jinnin,
F. Muchemwa,
T. Makino,
I. Kajihara,
K. Makino,
...
N. Honda,
K. Sakai,
S. Fukushima,
H. Ihn
|
5 |
2011 |
5
π
|
|
π
|
Serum levels of soluble CD163 in patients with systemic sclerosis
8 auth.
Wakana Nakayama,
M. Jinnin,
K. Makino,
I. Kajihara,
T. Makino,
S. Fukushima,
...
Y. Inoue,
H. Ihn
|
5 |
2012 |
5
π
|
|
π¦
|
Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of SystemicΒ Sclerosis.
7 auth.
K. Makino,
T. Makino,
L. Stawski,
Julio C. Mantero,
R. Lafyatis,
R. Simms,
...
M. Trojanowska
|
5 |
2017 |
5
π¦
|
